Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET
Company Participants
Ezgi Yagci - Vice President of Investor Relations
Tim Herbert - President and Chief Executive Officer
Rick Buchholz - Chief Financial Officer
Conference Call Participants
Danielle Antalffy - UBS Securities LLC
Robert Marcus - JPMorgan Chase & Co.
Lei Huang - Wells Fargo & Company
Travis Steed - Bank of America
Jonathan Block - Stifel Financial Corp.
Richard Newitter - Truist Securities
Adam Maeder - Piper Sandler Companies
Chris Pasquale - Nephron Research LLC
David Rescott - Robert W. Baird & Co.
Anthony Petrone - Mizuho Securities USA
Mike Kratky - Leerink Partners LLC
Mike Polark - Wolfe Research, LLC
Suraj Kalia - Oppenheimer & Co. Inc.
Operator
Good afternoon. My name is Dilam [ph], and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Inspire Medical System’s third quarter 2023 conference call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks there’ll be a question-and-answer session.
I’ll now hand the call over to your first speaker Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Ezgi Yagci
Thank you, DeLem, and thank you all for participating in today’s call. Joining me are Tim Herbert, President and Chief Executive Officer; and Rick Buchholz, chief financial officer. Earlier today, we released financial results for the 3 and 9 months ended September 30, 2023. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the federal securities law. All forward-looking statements including without limitation those relating to our operations, financial results and financial condition, investments in our business, full-year 2023 financial and operational outlook and changes in market access are based upon our current estimates and various assumptions.
These statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements. Please see our filings with the Securities and Exchange Commission including our F10-Q, which was filed with the SEC earlier this afternoon for a description of these risks and uncertainties.
Inspire disclaims any intention or obligation, except as required by law to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. This conference call contains time-sensitive information and speaks only as of the live broadcast today November 7, 2023.